Epileptogenesis causes an N-methyl-d-aspartate receptor/Ca2+-dependent decrease in Ca2+/calmodulin-dependent protein

Robert E Blair1, Sompong Sombati, Severn B Churn

  • 1Department of Neurology, Virginia Commonwealth University, School of Medicine, Richmond, Virginia 23298-0599, United States. rblair@vcu.edu

Insights

This study reveals that Ca2+/N-methyl-d-aspartate (NMDA) receptor activation mediates the decrease in CaM kinase II activity during low magnesium-induced epilepsy models, potentially contributing to seizure maintenance.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Epilepsy Research

Background:

  • Alterations in Ca2+/calmodulin-dependent protein kinase II (CaM kinase II) function are implicated in epileptogenesis.
  • The precise molecular mechanisms linking epilepsy to CaM kinase II dysfunction remain unclear.

Purpose of the Study:

  • To investigate the molecular pathways responsible for reduced CaM kinase II activity in a hippocampal culture model of low magnesium-induced spontaneous recurrent epileptiform discharges (SREDs).

Main Methods:

  • Utilized a low Mg2+ hippocampal neuronal culture model to induce SREDs.
  • Assessed CaM kinase II activity via substrate phosphorylation (autocamtide-2).
  • Examined the role of Ca2+ levels, NMDA receptors, AMPA/kainate receptors, and L-type Ca2+ channels using specific antagonists and reduced extracellular Ca2+.

Main Results:

  • Low Mg2+-induced SREDs significantly decreased CaM kinase II-dependent substrate phosphorylation.
  • Reducing extracellular Ca2+ or adding APV (NMDA receptor antagonist) blocked this decrease.
  • AMPA/kainate receptor antagonists and L-type Ca2+ channel blockers did not affect the CaM kinase II activity reduction.

Conclusions:

  • The reduction in CaM kinase II activity during low Mg2+-induced SREDs is mediated by a selective Ca2+/NMDA receptor-dependent pathway.
  • This mechanism may play a role in the generation and persistence of SREDs in this epilepsy model.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Integration of Synaptic Events01:28

Integration of Synaptic Events

Synaptic integration mainly includes the summation of graded potentials. Graded potentials, regardless of their type, cause subtle alterations in membrane voltage, resulting in either depolarization or hyperpolarization. These incremental changes, when combined or summed, can propel the neuron toward its threshold. Consider, for example, a membrane experiencing a +15 mV shift, causing it to depolarize from -70 mV to -55 mV. In this scenario, graded potentials govern the membrane's ability to...